Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good find gixer , DSM seem to still be working hard on FF.
Looks like the product is for cholesterol ?
W$
Not sure when this one was launched.
http://www.bio-rankan.com/index.php?option=product&lang=cht&task=pageinfo&id=257&belongid=249&index=1
It was noted at the time that the R&D spend for last year was, for the first time, greater than the losses for the year
https://i.postimg.cc/pdVcZbSz/1.jpg
Was mentioned that sales were lower in q1. I think a similar loss to last year. Plenty of cash so no raise unless we need extra for the Fruitflow we need for bi-health
W$,
Thanks for the info. So if the trend continues then we could in breakeven or in slight profit this year. On top of that the BY Health things are coming.
DP
I posted this some time ago, but non FF+ revenues to us did rise significantly in 2021
(in green)
https://postimg.cc/nXKZXt1h
W$
As ususal great find gixer. Hope all these will reflect in our SP soon.
Cardio Fortis TV advert.
https://www.youtube.com/watch?v=-WWX48YhFaE&t=469s
WS,
Certainly hoping for something this year, but....
My expectations are
SAMR submission - end of June
SAMR approval - end of September
Start of By-Health Contract - January
Fist Major Product Launch - March/April.
Let's see just how wrong I am :)
Also hoping that they have a number of other Chinese business customers lined up on the distribution side of things.
What are other people's expectations for milestone dates?
CB
We are all repeating ourselves. We just have to be patient (unfortunately). Personally took some out and traded elsewhere.....
W$
wellsite. Agreed, Fruitflow is a super product. Pity it's with its current custodians though! DSM never really lived up to expectations IMO.
Dr
for me the big unknown is whether IF et al can achieve something out with the BH realm this year.
DSM agreement, long CV, nitrates , aspirin, US breakthrough are some of the areas I'm hoping to see material updates in this year.
W$
We all know that the timeline is broadly this year for SAMR approvals, next year for major product launches. This transformation will put PXS on the radar. I am just hoping that the current Covid lockdowns in China are not impacting that timeline. They are bat**** crazy with their zero Covid policy.
For you not the person who owns 209m of PXS share. He is also a top investor and must a reason why he invested so heavily in PXS. Probably no too far now.
CB
Share may be forgotten, but FF isn't.
The SP is carp for the technology we have... Surely you can see the potential for a significant rise leading to an eventual takeover by either BH or DSM or even a pharma like Bayer ?
W?
This share is long forgotten and off any radar. That’s why it has a crazy large spread. We all hope that changes when they move into profit off the back of BH orders and then the radar picks it up again.
Ever, funniest thing I've read for a while! This share is long forgotten and off any radar!
Especially as there are lots of other places (Energy Stocks) that are giving much better returns atm...
Just spotted we are the headline act in a new book to be published in June 2022.
https://www.researchandmarkets.com/reports/5342398/functional-foods-and-their-implications-for#src-pos-1
W$
Around £8.5k. Maybe not a lot but nice to see a large buy when volume has been so low.
Around £8.5k. Maybe not a lot but nice to see a large buy when volume has been so low.
that is £10 K not a lot really but the spread is 25% SO THEY ARE TRYING TO PUT PEOPLE OFF.
1 million buy showing on Aquis.
To be honest I have no idea when this trial/study was completed. It could be recent or it could have been from a while ago and they have just decided to publish the results.
As for Blue Hat/Cap......
The last thing we were told was
"By-Health’s regulatory clearance preparations for Fruitflow were originally focussed on obtaining blue cap
health claim status for some Fruitflow based products in China, under the existing 27 permitted health function
claim structure.
By-Health is now working on an extensive regulatory submission to the SAMR for Fruitflow, seeking to establish
a new permitted health function claim for foods such as Fruitflow that can demonstrate an anti-platelet effect,
inhibiting platelet function and conferring beneficial effects for people who are at risk of platelet hyperactivity associated thrombosis - the aberrant blood clots which lead to heart attacks and strokes."
Hoping that we might get a trading update this year but who knows.
Gixer,
Do we know if this represents the completion of one of the "Blue Hat" trials. If not, do we know how the outstanding Blue Hat trials are progressing.
Received: 07 Mar 2022; Accepted: 25 Apr 2022.
Provisionally accepted
The final version of the article will be published here soon pending final quality checks
Four-week supplementation of water-soluble tomato extract attenuates platelet function in Chinese healthy middle-aged and older individuals: A randomized, double-blinded, crossover clinical trial.
https://www.frontiersin.org/articles/10.3389/fnut.2022.891241/full